10
Jul
2023
Detecting Cancer Early When It’s Most Treatable: Kevin Conroy on The Long Run
Today’s guest on The Long Run is Kevin Conroy. Kevin is the chairman and CEO of Madison, Wis.-based Exact Sciences. Exact Sciences has grown over the past decade into a success story for cancer screening and diagnosis. It’s best known for marketing the noninvasive Cologuard test that screens people for colorectal cancer. It also markets the Oncotype DX test that’s... Read More
10
Jul
2023
Lessons Learned from the Intense Back-and-Forth Over a $1B Acquisition
Since 2018, about 90 biotech companies have been acquired for more than $500 million. That’s only about 15 to 20 companies per year, a tiny fraction of the approximately 10,000 biotechnology companies around the world. I was privileged to be part of one of those transactions, the sale of Albireo Pharma to Ipsen in January for $952 million upfront, plus... Read More